(Q28243881)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871155%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

review article

1 reference

title

Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871155%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871155%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

Simona Pichini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871155%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

author name string

Magí Farré

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871155%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

Mónica Navarro

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871155%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

Roberta Pacifici

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871155%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

Piergiorgio Zuccaro

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871155%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

language of work or name

English

0 references

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871155%20AND%20SRC:MED&resulttype=core&format=json

Clinical Pharmacokinetics

20 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871155%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871155%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871155%20AND%20SRC:MED&resulttype=core&format=json

20 November 2019

page(s)

157-185

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871155%20AND%20SRC:MED&resulttype=core&format=json

The metabolic fate of 3H-fenetylline in man

20 November 2019

cites work

1 reference

12 December 2020

Further evidence that amphetamines produce long-lasting dopamine neurochemical deficits by destroying dopamine nerve fibers

1 reference

12 December 2020

Structure-activity relationships of the classic hallucinogens and their analogs

1 reference

12 December 2020

Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4-methylenedioxymethamphetamine in humans

1 reference

12 December 2020

Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens

1 reference

12 December 2020

Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers

1 reference

12 December 2020

Amphetamine metabolism in amphetamine psychosis

1 reference

12 December 2020

Steady-state pharmacokinetics of phentermine extended-release capsules

1 reference

12 December 2020

Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction

1 reference

12 December 2020

Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue

1 reference

12 December 2020

CYP2D6 deficiency, a factor in ecstasy related deaths?

1 reference

12 December 2020

Urinary methamphetamine concentration following famprofazone administration

1 reference

12 December 2020

Stereospecific Derivatization of Amphetamines, Phenol Alkylamines, and Hydroxyamines and Quantification of the Enantiomers by Capillary GC/MS

1 reference

12 December 2020

Amphetamine: effects on catecholamine systems and behavior

1 reference

12 December 2020

Analysis of 4-methylthioamphetamine in clinical specimens

1 reference

12 December 2020

On-site testing of saliva and sweat with Drugwipe and determination of concentrations of drugs of abuse in saliva, plasma and urine of suspected users

1 reference

12 December 2020

The chemorelease of norepinephrine in mouse hearts. Structure-activity relationships. II. Drugs affecting the sympathetic and central nervous systems

1 reference

12 December 2020

Interindividual and interspecies variation in the metabolism of the hallucinogen 4-methoxyamphetamine

1 reference

12 December 2020

The application of saliva, sweat and tear fluid for diagnostic purposes

1 reference

12 December 2020

Fatal 4-MTA intoxication: development of a liquid chromatographic-tandem mass spectrometric assay for multiple matrices

1 reference

12 December 2020

Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans

1 reference

12 December 2020

Detection of amphetamines in fingernails: an alternative to hair analysis

1 reference

12 December 2020

Loss of dopamine transporters in methamphetamine abusers recovers with protracted abstinence.

1 reference

12 December 2020

Determination of "Ecstasy" components in alternative biological specimens.

1 reference

12 December 2020

Clinical effects of methamphetamine vapor inhalation

1 reference

12 December 2020

alpha-Methyldopamine, a key intermediate in the metabolic disposition of 3,4-methylenedioxyamphetamine in vivo in dog and monkey

1 reference

12 December 2020

Pharmacokinetics of oral methamphetamine and effects of repeated daily dosing in humans

1 reference

12 December 2020

CYP2C19 polymorphism is not important for the in vivo metabolism of selegiline

1 reference

12 December 2020

Usefulness of saliva for measurement of 3,4-methylenedioxymethamphetamine and its metabolites: correlation with plasma drug concentrations and effect of salivary pH.

1 reference

12 December 2020

Profiles of urine samples taken from Ecstasy users at Rave parties: analysis by immunoassays, HPLC, and GC-MS.

1 reference

12 December 2020

Pharmacokinetics of a single dose of phenylpropanolamine following oral administration at two different times of the day

1 reference

12 December 2020

The bioavailability of intranasal and smoked methamphetamine

1 reference

12 December 2020

CYP2D6 polymorphism is not crucial for the disposition of selegiline*

1 reference

12 December 2020

Hair analysis for drug abuse. XV. Disposition of 3, 4-methylenedioxymethamphetamine (MDMA) and its related compounds into rat hair and application to hair analysis for MDMA abuse

1 reference

12 December 2020

Excretion of MBDB and BDB in urine, saliva, and sweat following single oral administration

1 reference

12 December 2020

Hair analysis for drugs of abuse. III. Movement and stability of methoxyphenamine (as a model compound of methamphetamine) along hair shaft with hair growth

1 reference

12 December 2020

Analysis of methamphetamine in hair, nail, sweat, and saliva by mass fragmentography

1 reference

12 December 2020

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals

1 reference

12 December 2020

Nails as useful materials for detection of methamphetamine or amphetamine abuse

1 reference

12 December 2020

Gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS) in toxicological analysis. Studies on the detection of clobenzorex and its metabolites within a systematic toxicological analysis procedure by GC-MS and

1 reference

12 December 2020

Enzymatic and chemical demethylenation of (methylenedioxy)amphetamine and (methylenedioxy)methamphetamine by rat brain microsomes

1 reference

12 December 2020

Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy')

1 reference

12 December 2020

Studies on the metabolism and toxicological detection of the amphetamine-like anorectic fenproporex in human urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay

1 reference

12 December 2020

Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users.

1 reference

12 December 2020

The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system

1 reference

12 December 2020

Methamphetamine and ethanol interactions in humans.

1 reference

12 December 2020

3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics.

1 reference

12 December 2020

Methamphetamine--a metabolite of the anorectics Benzphetamine and Furfenorex

1 reference

12 December 2020

Non-linear pharmacokinetics of MDMA ('ecstasy') in humans

1 reference

12 December 2020

Inhibitory metabolite complex formation of methylenedioxymethamphetamine with rat and human cytochrome P450. Particular involvement of CYP 2D

1 reference

12 December 2020

Qualitative detection of opiates in sweat by EIA and GC-MS.

1 reference

12 December 2020

Comparative pharmacodynamic activity of 3 anorexic drugs: D-amphetamine, phenmetrazine, diethylpropion. I. Behavior, toxicity, spontaneous activity

1 reference

12 December 2020

Single dose treatment of fungal nail disease

1 reference

12 December 2020

Detection of amphetamine following administration of fenproporex

1 reference

12 December 2020

The metabolism of phenmetrazine in man and laboratory animals

1 reference

12 December 2020

Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans

1 reference

12 December 2020

3,4-Dihydroxymethamphetamine (HHMA). A major in vivo 3,4-methylenedioxymethamphetamine (MDMA) metabolite in humans

1 reference

12 December 2020

Illegal or legitimate use? Precursor compounds to amphetamine and methamphetamine

1 reference

12 December 2020

INFLUENCE OF URINARY pH ON EXCRETION OF AMPHETAMINE

1 reference

12 December 2020

Urinary excretion of p-hydroxylated methamphetamine metabolites in man. II. Effect of alcohol intake on methamphetamine metabolism

1 reference

12 December 2020

Appetite suppressant drugs as inhibitors of human cytochromes P450: in vitro inhibition of P450-2D6 by D- and L-fenfluramine, but not phentermine

1 reference

12 December 2020

The metabolism and urinary excretion in man of phentermine, and the influence of N-methyl and p-chloro-substitution.

1 reference

12 December 2020

Selegiline metabolism and cytochrome P450 enzymes: in vitro study in human liver microsomes

1 reference

12 December 2020

Hair analysis for drug abuse. XIV. Identification of substances causing acute poisoning using hair root. I. Methamphetamine

1 reference

12 December 2020

Enantio-selective cognitive and brain activation effects of N-ethyl-3,4-methylenedioxyamphetamine in humans

1 reference

12 December 2020

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

1 reference

12 December 2020

Determination of amphetamine, methamphetamine and amphetamine-derived designer drugs or medicaments in blood and urine

1 reference

12 December 2020

Immunohistochemical study on the excretion of a drug (methamphetamine) by salivary glands

1 reference

12 December 2020

Stereochemistry: definitions and a note on nomenclature

1 reference

12 December 2020

The influence of replacement of the N-ethyl group by the cyanoethyl group on the absorption, distribution and metabolism of (plus or minus)-ethylamphetamine in man

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic principles of illicit drug use and treatment of illicit drug users

1 reference

12 December 2020

Identification of the human cytochromes P450 involved in the oxidative metabolism of "Ecstasy"-related designer drugs

1 reference

12 December 2020

Fatal interaction between ritonavir and MDMA

1 reference

12 December 2020

Amphetamine blood and urine levels in man

1 reference

12 December 2020

Metabolic production of amphetamine following multidose administration of clobenzorex

1 reference

12 December 2020

The pharmacokinetics of dexfenfluramine in obese and non-obese subjects

1 reference

12 December 2020

Chemical analysis of ecstasy pills

1 reference

12 December 2020

Interactions of amphetamine analogs with human liver CYP2D6

1 reference

12 December 2020

Availability of phendimetrazine from sustained and non-sustained action formulations

1 reference

12 December 2020

Bioavailability of amfepramone hydrochloride sustained release pellets formulation in healthy subjects

1 reference

12 December 2020

Fatalities caused by the MDMA-related drug paramethoxyamphetamine (PMA).

1 reference

12 December 2020

Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment

1 reference

12 December 2020

Testing for drugs in hair. Critical review of chromatographic procedures since 1992.

1 reference

12 December 2020

The properties of 3,4-methylenedioxyamphetamine (MDA). I. A review of the literature

1 reference

12 December 2020

Metabolism of N,N-dialkylated amphetamines, including deprenyl, by CYP2D6 expressed in a human cell line

1 reference

12 December 2020

Simultaneous hair testing for opiates, cocaine, and metabolites by GC-MS: a survey of applicants for driving licenses with a history of drug use.

1 reference

12 December 2020

Metabolism of methoxyphenamine and 2-methoxyamphetamine in P4502D6-transfected cells and cell preparations

1 reference

12 December 2020

Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS

1 reference

12 December 2020

Recent paramethoxyamphetamine deaths

1 reference

12 December 2020

Detection and identification of famprofazone and its metabolite in human urine

1 reference

12 December 2020

Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking

1 reference

12 December 2020

The metabolism of (-)-ephedrine in man

1 reference

12 December 2020

Hair analysis for drugs of abuse. IX. Comparison of deprenyl use and methamphetamine use by hair analysis.

1 reference

12 December 2020

Reduced (+/-)-3,4-methylenedioxymethamphetamine ("Ecstasy") metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro.

1 reference

12 December 2020

Hair concentrations and self-reported abuse history of 20 amphetamine and ecstasy users

1 reference

12 December 2020

Pharmacokinetics and Clinical Effectiveness of Methylphenidate

1 reference

12 December 2020

Monitoring drug use with a sweat patch: an experiment with cocaine

1 reference

12 December 2020

Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram

1 reference

12 December 2020

Detection and diagnostic interpretation of amphetamines in hair

1 reference

12 December 2020

Methamphetamine and amphetamine derived from the metabolism of selegiline

1 reference

12 December 2020

Simultaneous determination of dimethylamphetamine and its metabolites in rat hair by gas chromatography-mass spectrometry

1 reference

12 December 2020

Drug monitoring in nonconventional biological fluids and matrices

1 reference

12 December 2020

Plasma, oral fluid and sweat wipe ecstasy concentrations in controlled and real life conditions

1 reference

12 December 2020

Cytochrome P450 2D6.1 and cytochrome P450 2D6.10 differ in catalytic activity for multiple substrates.

1 reference

12 December 2020

Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects

1 reference

12 December 2020

Quantitation of N-ethyl-3,4-methylenedioxyamphetamine and its major metabolites in human plasma by high-performance liquid chromatography and fluorescence detection

1 reference

12 December 2020

Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers

1 reference

12 December 2020

Clinical pharmacokinetics of non-opiate abused drugs

1 reference

12 December 2020

Quantification of amphetamine plasma concentrations by gas chromatography coupled to mass spectrometry

1 reference

12 December 2020

Ice: a new dosage form of an old drug

1 reference

12 December 2020

Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research

1 reference

12 December 2020

Biochemical approach on the conservation of drug molecules during hair fiber formation

1 reference

12 December 2020

Urinary Excretion of Methylamphetamine in Man

1 reference

12 December 2020

Fatal poisoning with a new phenylethylamine: 4-methylthioamphetamine (4-MTA)

1 reference

12 December 2020

Pharmacodynamics and pharmacokinetics of single nasal (5 mg and 10 mg) and oral (50 mg) doses of ephedrine in healthy subjects

1 reference

12 December 2020

Locomotor activity and anorexogenic action

1 reference

12 December 2020

Routine detection and identification in urine of stimulants and other drugs, some of which may be used to modify performance in sport

1 reference

12 December 2020

Pharmacokinetics of the orally administered decongestants pseudoephedrine and phenylpropanolamine in children

1 reference

12 December 2020

Early pharmacokinetics and clinical effects of oral D-amphetamine in normal subjects

1 reference

12 December 2020

3,4-methylenedioxyamphetamine (MDA): analytical and forensic aspects of fatal poisoning

1 reference

12 December 2020

Interaction between ethanol and dextroamphetamine: effects on psychomotor performance

1 reference

12 December 2020

Hair analysis for drugs of abuse. XI. Disposition of benzphetamine and its metabolites into hair and comparison of benzphetamine use and methamphetamine use by hair analysis

1 reference

12 December 2020

Stereospecific analysis and enantiomeric disposition of 3, 4-methylenedioxymethamphetamine (Ecstasy) in humans

1 reference

12 December 2020

The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers.

1 reference

12 December 2020

Relationships between pharmacokinetic and clinical parameters in chronic amphetamine abuse

1 reference

12 December 2020

Hair analysis for drug abuse: I. Determination of methamphetamine and amphetamine in hair by stable isotope dilution gas chromatography/mass spectrometry method

1 reference

12 December 2020

3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brain

1 reference

12 December 2020

Toxicological detection of selegiline and its metabolites in urine using fluorescence polarization immunoassay (FPIA) and gas chromatography-mass spectrometry (GC-MS) and differentiation by enantioselective GC-MS of the intake of selegiline from abu

1 reference

12 December 2020

Psychological effects of MDE in normal subjects. Are entactogens a new class of psychoactive agents?

1 reference

12 December 2020

Single-Dose Pharmacokinetics of Methylphenidate in CYP2D6 Extensive and Poor Metabolizers

1 reference

12 December 2020

Amphetamine-positive drug screens from use of clobenzorex hydrochlorate

1 reference

12 December 2020

Amphetamine concentrations in human urine following single-dose administration of the calcium antagonist prenylamine-studies using fluorescence polarization immunoassay (FPIA) and GC-MS.

1 reference

12 December 2020

1 reference

12 December 2020

Passage of drugs across body membranes

1 reference

12 December 2020

Kinetics, salivary excretion of amphetamine isomers, and effect of urinary pH

1 reference

12 December 2020

Some new urinary metabolites of famprofazone and morazone in man.

1 reference

12 December 2020

Cocaine and metabolite excretion in saliva under stimulated and nonstimulated conditions.

1 reference

12 December 2020

The metabolism of 1-phenyl-2-(N-methyl-N-benzylamino)propane (benzphetamine) and 1-phenyl-2-(N-methyl-N-furfurylamino)propane (furfenorex) in man.

1 reference

12 December 2020

Simultaneous determination of amphetamine, methamphetamine, 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamphetamine in human hair by gas chromatography-mass spectrometry

1 reference

12 December 2020

Deprenyl is metabolized to methamphetamine and amphetamine in man

1 reference

12 December 2020

Stereoselective screening for and confirmation of urinary enantiomers of amphetamine, methamphetamine, designer drugs, methadone and selected metabolites by capillary electrophoresis

1 reference

12 December 2020

Quantitative determination of enantiomeric compounds. I—simultaneous measurement of the optical isomers of amphetamine in human plasma and saliva using chemical ionization mass spectrometry

1 reference

12 December 2020

Drug interactions with psychostimulants

1 reference

12 December 2020

MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks

1 reference

12 December 2020

The metabolism, distribution and elimination of chlorphentermine in man

1 reference

12 December 2020

Involvement of CYP2D6 in the in vitro metabolism of amphetamine, two N-alkylamphetamines and their 4-methoxylated derivatives

1 reference

12 December 2020

Studies on the metabolism and toxicological detection of the amphetamine-like anorectic mefenorex in human urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay

1 reference

12 December 2020

Usefulness of sweat testing for the detection of MDMA after a single-dose administration

1 reference

12 December 2020

Oxidation of methamphetamine and methylenedioxymethamphetamine by CYP2D6.

1 reference

12 December 2020

Hydrogen peroxide production in mouse tissues after acute d-amphetamine administration. Influence of monoamine oxidase inhibition.

1 reference

12 December 2020

Knowledge and experience of young people regarding drug misuse, 1969-94.

1 reference

12 December 2020

3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans.

1 reference

12 December 2020

Development and validation of a gas chromatography-mass spectrometry assay for hair analysis of amphetamine, methamphetamine and methylenedioxy derivatives

1 reference

12 December 2020

Sweat testing in opioid users with a sweat patch

1 reference

12 December 2020

Striatal dopamine nerve terminal markers in human, chronic methamphetamine users

1 reference

12 December 2020

Concordance between self-reported drug use and findings in hair about cocaine and heroin.

1 reference

12 December 2020

History of hair analysis.

1 reference

12 December 2020

ANOREXIGENIC AGENTS: AROMATIC SUBSTITUTED 1-PHENYL-2-PROPYLAMINES

1 reference

12 December 2020

Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts

1 reference

12 December 2020

Metabolic fate of fenetylline in rat and man

1 reference

12 December 2020

Pharmacokinetics of pemoline in plasma, saliva and urine following oral administration

1 reference

12 December 2020

Chronopharmacokinetics and chronopharmacodynamics of dextromethamphetamine in man.

1 reference

12 December 2020

Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

1 reference

12 December 2020

The demethylenation of methylenedioxymethamphetamine ("ecstasy") by debrisoquine hydroxylase (CYP2D6)

1 reference

12 December 2020

Role of quinones in toxicology.

1 reference

12 December 2020

Toxicokinetics of amphetamines: metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their N-alkyl derivatives

1 reference

12 December 2020

Determination of MDMA and its metabolites in blood and urine by gas chromatography-mass spectrometry and analysis of enantiomers by capillary electrophoresis

1 reference

12 December 2020

Cytochrome P-455 nm complex formation in the metabolism of phenylalkylamines. XII. Enantioselectivity and temperature dependence in microsomes and reconstituted cytochrome P-450 systems from rat liver

1 reference

12 December 2020

Aminorex produces stimulus effects similar to amphetamine and unlike those of fenfluramine

1 reference

12 December 2020

Analytical profile of 4-methylthioamphetamine (4-MTA), a new street drug

1 reference

12 December 2020

Excretion of amphetamines in human sweat

1 reference

12 December 2020

Deamination of amphetamines by cytochromes P450: studies on substrate specificity and regioselectivity with microsomes and purified CYP2C subfamily isozymes

1 reference

12 December 2020

Clinical effects of daily methamphetamine administration

1 reference

12 December 2020

Detection of methamphetamine in sweat by EIA and GC-MS

1 reference

12 December 2020

Testing for drugs of abuse in saliva and sweat

1 reference

12 December 2020

Single- and multiple-dose pharmacokinetics of an oral once-a-day osmotic controlled-release OROS (methylphenidate HCl) formulation

1 reference

12 December 2020

Determination of amphetamine and methylenedioxy-amphetamine-derivatives in hair

1 reference

12 December 2020

Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride

1 reference

12 December 2020

10.2165/00003088-200443030-00002

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14871155%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

20 November 2019

1043899982

0 references

1 reference